To our knowledge, variant-specific expression of OCT4 transcripts could not be assessed using currently available high-throughput databases [18, 24]; therefore, in the present study, we explored the potential of multiple OCT4 transcript variants to act as prognostic biomarkers in human somatic cancers. This evidence concerns the gene POU5F1 and cancer.